Teva Launches Generic Glucose Control Tablets in U.S.
Teva Pharmaceutical Industries announced the launch of an authorized generic of Actos (pioglitazone-hydrochloride tablets) 15, 30 and 45mg. Actos is marketed by Takeda Pharmaceuticals U.S.A., Inc., and used with diet and exercise for blood sugar control in adults with type 2 diabetes.
The brand product had annual sales of approximately $2.7 billion in the United States, based on IMS sales data as of June 30.
Teva Pharmaceutical is a pharmaceutical company that develops generic drugs as well as specialty pharmaceuticals and active pharmaceutical ingredients.
Source: ProQuest Information and Learning Co.